BackAcorda Therapeutics Overview

Acorda Therapeutics Total Assets

Track Acorda Therapeutics's total assets ($82M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$81.58M
↓ 78.24% YoYΔ $-293.33M vs prior year quarter

Peer trimmed avg / median

Loading

Acorda Therapeutics Total Assets History

Loading

Acorda Therapeutics vs. peers: Total Assets Comparison

Loading

Acorda Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acorda Therapeutics (ACOR) FAQ

Acorda Therapeutics posts a total assets of $82M as of March 2024. That compares with $370M in the prior-year period — down 78.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Acorda Therapeutics's total assets was $370M. The latest reading is $82M — a 78.2% year-over-year decrease (period ending March 2024). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Acorda Therapeutics's financial statement story. At $82M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ACOR's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Acorda Therapeutics's other metric pages and overview cover the third.

Judging Acorda Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $82M here, then scan peer and history charts to see if the gap is persistent.